Albion Financial Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-185
| Closed | -$18.8K | – | 752 |
|
|
2025
Q4 | $18.8K | Hold |
185
| – | – | ﹤0.01% | 351 |
|
|
2025
Q3 | $10.1K | Hold |
185
| – | – | ﹤0.01% | 393 |
|
|
2025
Q2 | $9.83K | Hold |
185
| – | – | ﹤0.01% | 368 |
|
|
2025
Q1 | $8.01K | Hold |
185
| – | – | ﹤0.01% | 387 |
|
|
2024
Q4 | $10.4K | Hold |
185
| – | – | ﹤0.01% | 395 |
|
|
2024
Q3 | $12.6K | Hold |
185
| – | – | ﹤0.01% | 320 |
|
|
2024
Q2 | $7.82K | Hold |
185
| – | – | ﹤0.01% | 349 |
|
|
2024
Q1 | $12.8K | Hold |
185
| – | – | ﹤0.01% | 300 |
|
|
2023
Q4 | $13.7K | Hold |
185
| – | – | ﹤0.01% | 289 |
|
|
2023
Q3 | $12.6K | Sell |
185
-500
| -73% | -$42.4K | ﹤0.01% | 283 |
|
|
2023
Q2 | $64.3K | Hold |
685
| – | – | 0.01% | 216 |
|
|
2023
Q1 | $46.5K | Sell |
685
-40
| -6% | -$2.57K | ﹤0.01% | 213 |
|
|
2022
Q4 | $35.9K | Buy |
725
+40
| +6% | +$1.63K | ﹤0.01% | 225 |
|
|
2022
Q3 | $22K | Hold |
685
| – | – | ﹤0.01% | 248 |
|
|
2022
Q2 | $27K | Buy |
685
+185
| +37% | +$9.89K | ﹤0.01% | 250 |
|
|
2022
Q1 | $35K | Sell |
500
-4
| -0.8% | -$292 | ﹤0.01% | 276 |
|
|
2021
Q4 | $39K | Sell |
504
-13
| -3% | -$1.15K | ﹤0.01% | 300 |
|
|
2021
Q3 | $49K | Hold |
517
| – | – | ﹤0.01% | 251 |
|
|
2021
Q2 | $64K | Buy |
+517
| New | +$61.7K | 0.01% | 236 |
|
|
2020
Q4 | $68K | Buy |
+517
| New | +$62.5K | 0.01% | 224 |
|
|
2018
Q3 | – | Sell |
-12,816
| Closed | -$766K | – | 199 |
|
|
2018
Q2 | $766K | Sell |
12,816
-445
| -3% | -$23.9K | 0.11% | 109 |
|
|
2018
Q1 | $535K | Buy |
+13,261
| New | +$647K | 0.08% | 121 |
|
|
2017
Q4 | – | Sell |
-5,953
| Closed | -$281K | – | 193 |
|
|
2017
Q3 | $281K | Hold |
5,953
| – | – | 0.04% | 160 |
|
|
2017
Q2 | $211K | Buy |
+5,953
| New | +$184K | 0.04% | 180 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Albion Financial Group's EXAS Position: Q1 2026 in Review
Albion Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 185 shares — an estimated $18.8K sold.
Albion Financial Group first reported a position in EXAS in Q2 2017 and held it in 24 quarters. The position peaked at $766K in Q2 2018. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Albion Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Albion Financial Group sold 185 Exact Sciences shares in Q1 2026, an estimated $18.8K.
- Albion Financial Group first reported a position in Exact Sciences in Q2 2017 and held it in 24 quarters.
- Albion Financial Group's Exact Sciences position peaked at $766K in Q2 2018.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.